Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2018-003789-15Phase 4Active
Phase 4, randomised, double-blind trial in chronic heart failure (CHF) comparing Low-dose digoxin with Placebo (2 arms). Primary endpoint: Composite of repeated heart failure hospitalizations and cardiovascular death. Started Jan 2019; status: active.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2018-003789-15.